Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis

Arthritis Care & Research(2024)10.1002/acr.25417Source: DataRank Database

Biomarker Changes in Response to Tofacitinib Treatment in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis is a research paper published in Arthritis Care & Research (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

Deposits data Open Access1 citations

Download PDF

Cite:

Linked data & code

nct

Data availability

Repositories this paper deposited data in (declared in PubMed).

ClinicalTrials.govNCT02592434

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 0.30)OA: hybridTopics (59)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (18)

Hermine I. Brunner ORCID,Esraa M. Eloseily ORCID,Yonatan Butbul Aviel ORCID,Kabita Nanda ORCID,Heinrike Schmeling ORCID

Live enrichment

PubMed:39135452 PMC:PMC11605783 OpenAlex:https://openalex.org/W4401550663

National Institutes of Health

Grant: 5P30AR076316

National Institutes of Health

Grant: P30 AR070549

NCATS NIH HHS

Grant: UM1 TR004400

NIAMS NIH HHS

Grant: P30 AR076316

National Institutes of Health

Grant: 5P30AR076316-02

Pediatric musculOskeletal & RheumaTology Innovation COre center (PORTICO)

National Institutes of Health

Grant: 5P30AR070549-03

Cincinnati Rheumatic Diseases Resource Center

Ralph & Marian Falk Medical Trust Catalyst Award

Cincinnati Children's Hospital Medical Center Pediatric Musculoskeletal & Rheumatology Innovation Core center (PORTICO)

Pfizer

Ralph & Marian Falk Medical Trust Catalyst Award

Pfizer

Cincinnati Children's Hospital Medical Center Pediatric Musculoskeletal & Rheumatology Innovation Core center (PORTICO)

FWCI

0.30

Citation Percentile

0.6%

Citation Trend

2024

hybridLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr.25417

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acr.25417

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/acr.25417

journalhttps://doi.org/10.1002/acr.25417

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39135452

Fields of Study

Autoimmune and Inflammatory Disorders ResearchRheumatoid Arthritis Research and TherapiesSpondyloarthritis Studies and Treatments03 medical and health sciences0302 clinical medicineHumansArthritis, JuvenilePiperidinesFemaleMaleChildBiomarkersPyrimidinesAdolescentTreatment OutcomeChild, PreschoolJanus Kinase InhibitorsProtein Kinase Inhibitors

MeSH Terms

Janus Kinase InhibitorsAdolescentArthritis, JuvenileChildChild, PreschoolFemaleHumansMalePiperidinesPyrimidinesBiomarkersTreatment OutcomeProtein Kinase Inhibitors

Keywords

MedicineResistinInternal medicineTofacitinibTocilizumabGastroenterologyArthritisBiomarkerRheumatologyRheumatoid arthritisAdipokineLeptinObesityMaleAdolescentPediatricsArthritis, JuvenilePyrimidinesTreatment OutcomePiperidinesChild, PreschoolHumansJanus Kinase InhibitorsFemaleChildProtein Kinase InhibitorsBiomarkersAdolescent; Arthritis, Juvenile; Biomarkers; Child; Child, Preschool; Female; Humans; Janus Kinase Inhibitors; Male; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Treatment Outcome

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being